Sino Biopharmaceutical Limited (SBHMY)
USD 9.48
(-7.96%)
USD 9.48
(-7.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.12 Billion CNY | -41.28% |
| 2022 | 5.32 Billion CNY | 111.57% |
| 2021 | 2.51 Billion CNY | -29.78% |
| 2020 | 3.58 Billion CNY | 277.92% |
| 2019 | -2.01 Billion CNY | 28.6% |
| 2018 | -2.82 Billion CNY | -280.97% |
| 2017 | -740.84 Million CNY | -63.27% |
| 2016 | -453.74 Million CNY | 32.67% |
| 2015 | -673.94 Million CNY | 41.61% |
| 2014 | -1.15 Billion CNY | 47.55% |
| 2013 | -2.2 Billion CNY | -11.16% |
| 2012 | -1.97 Billion CNY | -20.79% |
| 2011 | -1.63 Billion CNY | 11.91% |
| 2010 | -1.86 Billion CNY | -15.72% |
| 2009 | -1.6 Billion CNY | -3.01% |
| 2008 | -1.56 Billion CNY | 2.98% |
| 2007 | -1.6 Billion CNY | 4.73% |
| 2006 | -1.68 Billion CNY | 4.35% |
| 2005 | -1.76 Billion CNY | -610.23% |
| 2004 | -248.57 Million CNY | -10.57% |
| 2003 | -224.81 Million CNY | 24.49% |
| 2002 | -297.7 Million CNY | -63.13% |
| 2001 | -182.49 Million CNY | -70.51% |
| 2000 | -107.02 Million CNY | -5880.66% |
| 1999 | -1.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 961.64 Million CNY | 17.2% |
| 2024 Q1 | 961.64 Million CNY | -69.26% |
| 2023 Q3 | 3.19 Billion CNY | 13908.2% |
| 2023 Q4 | 3.12 Billion CNY | -2.02% |
| 2023 Q2 | -23.12 Million CNY | 62.04% |
| 2023 FY | 3.12 Billion CNY | -41.28% |
| 2023 Q1 | -60.91 Million CNY | -101.14% |
| 2022 Q3 | 1.99 Billion CNY | -66.54% |
| 2022 FY | 5.32 Billion CNY | 111.57% |
| 2022 Q4 | 5.32 Billion CNY | 167.5% |
| 2022 Q1 | 4.19 Billion CNY | 66.77% |
| 2022 Q2 | 5.95 Billion CNY | 41.73% |
| 2021 Q4 | 2.51 Billion CNY | 55.4% |
| 2021 FY | 2.51 Billion CNY | -29.78% |
| 2021 Q1 | 5.87 Billion CNY | 63.82% |
| 2021 Q3 | 1.62 Billion CNY | -71.19% |
| 2021 Q2 | 5.62 Billion CNY | -4.24% |
| 2020 Q3 | 778.7 Million CNY | 186.38% |
| 2020 FY | 3.58 Billion CNY | 277.92% |
| 2020 Q1 | -698.09 Million CNY | 65.36% |
| 2020 Q2 | -901.48 Million CNY | -29.13% |
| 2020 Q4 | 3.58 Billion CNY | 360.46% |
| 2019 Q1 | -1.28 Billion CNY | 54.4% |
| 2019 Q2 | -3.06 Billion CNY | -137.86% |
| 2019 Q4 | -2.01 Billion CNY | -27.93% |
| 2019 FY | -2.01 Billion CNY | 28.6% |
| 2019 Q3 | -1.57 Billion CNY | 48.54% |
| 2018 Q4 | -2.82 Billion CNY | -27.83% |
| 2018 Q3 | -2.2 Billion CNY | -26.53% |
| 2018 Q2 | -1.74 Billion CNY | -9.47% |
| 2018 Q1 | -1.59 Billion CNY | -115.16% |
| 2018 FY | -2.82 Billion CNY | -280.97% |
| 2017 Q2 | -956.61 Million CNY | -5.55% |
| 2017 Q4 | -740.84 Million CNY | 61.49% |
| 2017 FY | -740.84 Million CNY | -63.27% |
| 2017 Q1 | -906.32 Million CNY | -99.74% |
| 2017 Q3 | -1.92 Billion CNY | -101.12% |
| 2016 Q1 | -828.24 Million CNY | -22.9% |
| 2016 FY | -453.74 Million CNY | 32.67% |
| 2016 Q4 | -453.74 Million CNY | 61.37% |
| 2016 Q3 | -1.17 Billion CNY | 28.7% |
| 2016 Q2 | -1.64 Billion CNY | -98.91% |
| 2015 FY | -673.94 Million CNY | 41.61% |
| 2015 Q1 | -1.17 Billion CNY | -1.37% |
| 2015 Q2 | -913.93 Million CNY | 21.89% |
| 2015 Q3 | -1.1 Billion CNY | -20.71% |
| 2015 Q4 | -673.94 Million CNY | 38.91% |
| 2014 Q3 | -2.11 Billion CNY | 9.55% |
| 2014 FY | -1.15 Billion CNY | 47.55% |
| 2014 Q4 | -1.15 Billion CNY | 45.46% |
| 2014 Q1 | -2.34 Billion CNY | -6.35% |
| 2014 Q2 | -2.33 Billion CNY | 0.02% |
| 2013 FY | -2.2 Billion CNY | -11.16% |
| 2013 Q3 | -2.22 Billion CNY | -8.19% |
| 2013 Q2 | -2.05 Billion CNY | 6.93% |
| 2013 Q1 | -2.2 Billion CNY | -11.52% |
| 2013 Q4 | -2.2 Billion CNY | 1.01% |
| 2012 FY | -1.97 Billion CNY | -20.79% |
| 2012 Q4 | -1.97 Billion CNY | 7.71% |
| 2012 Q3 | -2.14 Billion CNY | -14.66% |
| 2012 Q2 | -1.87 Billion CNY | 0.0% |
| 2011 Q3 | -1.75 Billion CNY | -5.47% |
| 2011 Q2 | -1.66 Billion CNY | -6.89% |
| 2011 Q1 | -1.56 Billion CNY | 0.0% |
| 2011 FY | -1.63 Billion CNY | 11.91% |
| 2011 Q4 | -1.63 Billion CNY | 6.86% |
| 2010 Q2 | -2.28 Billion CNY | 0.0% |
| 2010 FY | -1.86 Billion CNY | -15.72% |
| 2009 FY | -1.6 Billion CNY | -3.01% |
| 2009 Q4 | -1.6 Billion CNY | 0.0% |
| 2008 FY | -1.56 Billion CNY | 2.98% |
| 2007 FY | -1.6 Billion CNY | 4.73% |
| 2006 FY | -1.68 Billion CNY | 4.35% |
| 2005 FY | -1.76 Billion CNY | -610.23% |
| 2004 FY | -248.57 Million CNY | -10.57% |
| 2003 FY | -224.81 Million CNY | 24.49% |
| 2002 FY | -297.7 Million CNY | -63.13% |
| 2001 FY | -182.49 Million CNY | -70.51% |
| 2000 FY | -107.02 Million CNY | -5880.66% |
| 1999 FY | -1.78 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 464877.466% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -257614.55% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -310341.235% |
| Evofem Biosciences, Inc. | 42.79 Million USD | -7210.462% |
| GB Sciences, Inc. | 1.74 Million USD | -178938.365% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 35489.108% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 33753350.312% |
| Skye Bioscience, Inc. | -5.72 Million USD | 54778.436% |
| Zenith Capital Corp. | 10.06 Thousand USD | -31084617.806% |
| Agentix Corp. | 37.63 Thousand USD | -8313168.316% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -55285.288% |
| Biomind Labs Inc. | 711.4 Thousand USD | -439646.585% |
| ContraFect Corporation | -6.02 Million USD | 52014.471% |
| CSL Limited | 10.52 Billion USD | 70.28% |
| CytoDyn Inc. | 20.26 Million USD | -15339.572% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -869591.14% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -502558.573% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -7102.574% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 15329216.033% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -337304.361% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -492426.532% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 49720.971% |
| SQZ Biotechnologies Company | -36.23 Million USD | 8732.833% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -363561.579% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -19746.26% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -139420.112% |
| Mesoblast Limited | 55.85 Million USD | -5500.544% |
| Marizyme, Inc. | 18.56 Million USD | -16747.224% |
| Genus plc | 190.6 Million USD | -1541.325% |
| Pharming Group N.V. | 109.8 Million USD | -2749.046% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -459953.824% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -270653.633% |
| IMV Inc. | 7.67 Million USD | -40684.27% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -56759.781% |
| MultiCell Technologies, Inc. | 90.04 USD | -3474417936.428% |
| ONE Bio Corp. | 9.04 Million USD | -34505.685% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -24064.73% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -10138.81% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -156365.866% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -24327.783% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -2237579.895% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -15746444.521% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 1702260.098% |
| Enzolytics Inc. | 981.65 Thousand USD | -318582.512% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 254.195% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 6754.399% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -44142.376% |
| Genscript Biotech Corporation | -1.06 Billion USD | 394.758% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -75867.649% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -778392.916% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -131011.543% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -1901538.208% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 17078198.046% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -139819.547% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -2323421.417% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 426320.677% |
| Helix BioMedix, Inc. | -2.57 Million USD | 121824.788% |
| EV Biologics, Inc. | 1.36 Million USD | -228586.573% |
| Q BioMed Inc. | 4.06 Million USD | -76953.198% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -15328.911% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | -5066.946% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.47 Million USD | -69854.345% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -141970.526% |
| HST Global, Inc. | 96.79 Thousand USD | -3231916.778% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 238806664.885% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -1516926.239% |
| Halberd Corporation | 144.72 Thousand USD | -2161553.112% |
| Resverlogix Corp. | 6.45 Million USD | -48394.28% |
| Cell Source, Inc. | 9.23 Million USD | -33786.22% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -115396.887% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | -5.9 Million USD | 53094.347% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -1560711.647% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.17 Million USD | -143504.143% |
| Kadimastem Ltd | -253.1 Thousand USD | 1236109.988% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -2300355.184% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -1554336.682% |
| LadRx Corporation | -2.03 Million USD | 153717.168% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -492426.532% |
| Affymax, Inc. | -5.59 Million USD | 55993.622% |
| Itoco Inc. | 228.3 Thousand USD | -1370157.331% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -63010.067% |
| Mobile Lads Corp. | 484.23 Thousand USD | -645946.936% |
| International Stem Cell Corporation | 2.59 Million USD | -120686.332% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 1.89 Million USD | -164645.007% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 483518801.7% |
| Qrons Inc. | 351.42 Thousand USD | -890089.428% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -40496.486% |
| SYBLEU INC | 473.71 Thousand USD | -660291.291% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 1253351.342% |
| Rebus Holdings, Inc. | 305 Thousand USD | -1025593.77% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -70089.602% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -5012262.809% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -143343.808% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -90999.767% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -36476.242% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -404810.388% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 250369.28% |
| Neutra Corp. | 52.18 Thousand USD | -5994431.205% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 125787.666% |
| PureTech Health plc | -167.19 Million USD | 1971.066% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 1277463.745% |
| IXICO plc | -4.44 Million USD | 70485.977% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -23565.678% |
| Gelesis Holdings, Inc. | 54.85 Million USD | -5603.389% |
| CSL Limited | 10.52 Billion USD | 70.28% |
| Cellectis S.A. | -43.81 Million USD | 7239.312% |